Artelo Biosciences Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Business Update Jul 14, 2020 9:25am EDT
Artelo Biosciences Expands Stony Brook Commercial License Agreement for FABP5 Platform for Development of Lead Cancer, Pain and Inflammation Compounds Jun 29, 2020 8:30am EDT
Artelo Biosciences to Participate in BIO Digital and The Investor Summit Conferences Jun 03, 2020 9:30am EDT
Artelo Biosciences Awarded Composition of Matter Patent for Novel CBD Cocrystal May 12, 2020 9:30am EDT
Artelo Biosciences Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Business Update Apr 14, 2020 8:30am EDT
Artelo Biosciences to Present at Biocom’s 10th Annual Global Life Sciences Partnering Conference Feb 24, 2020 9:00am EST
Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Program Feb 03, 2020 8:30am EST
Artelo Biosciences Reports First Quarter Fiscal Year 2020 Financial Results and Provides Business Update Jan 14, 2020 8:00am EST
